[1]
S. Takasaki, Y. . Kawasaki, M. Kikuchi, A. Ito, H. Yamaguchi, and N. . Mano, “Clinical Importance of Plasma Drug Concentration of Oral Molecular Targeted Drugs for Renal Cell Carcinoma”, J Pharm Pharm Sci, vol. 24, pp. 127–136, Mar. 2021.